Skip to main content
. 2019 Oct 7;7(10):E1293–E1300. doi: 10.1055/a-0970-9005

Supplementary Table. Clinical and procedural data for included patients.

Case Clinical information ID-RFA setting Stents Adverse event Survival
Sex Age Diagnosis (Bismuth type) Length (mm) Power (W) Duration (sec) Tandem attempt (n) Type Unilateral/bilateral Number of stents (n) Death Follow-Up duration after ID-RFA (D)
 1 F 81 CCa (IV) 11 7 W  60 8 SEMS Bilateral 2 No No 163
 2 M 71 CCa (IV) 11 7 W  60 6 Plastic Bilateral 2 Fever No  82
 3 F 74 GB ca 11 7 W  60 3 SEMS Unilateral 1 Fever No  41
 4 F 64 CCa (IIIA) 11 7 W  60 3 SEMS Unilateral 2 No No 194
 5 M 75 CCa (IV) 11 7 W  60 2 SEMS Bilateral 2 Fever No 207
 6 M 63 Pan ca 11 7 W  60 4 SEMS Bilateral 2 Fever No  42
 7 M 70 CCa (IV) 11 7 W 120 4 SEMS Bilateral 2 No No  98
 8 F 80 CCa (IV) 11 7 W 120 4 SEMS Bilateral 2 Fever Yes 151
 9 F 66 GB ca 11 7 W 120 2 SEMS Bilateral 2 Fever/PEP Yes 191
10 F 87 CCa (IV) 11 7 W 120 3 SEMS Unilateral 1 No No  30
11 M 80 CCa (IV) 11 7 W  60 6 SEMS Bilateral 2 No No  30

ID-RFA, intraductal radiofrequency ablation; W, Watt; D, days; F, female; M, male; CCa, cholangiocarcinoma; GB ca, Gallbladder cancer; Pan Ca., pancreatic cancer with hepatic metastasis.